We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

40 hedge funds and large institutions have $30.9M invested in Milestone Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more call options, than puts

Call options by funds: $411K | Put options by funds: $160K

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 39 → 40 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3.4% less ownership

Funds ownership: 58.63% → 55.24% (-3.4%)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

49% less capital invested

Capital invested by funds: $60.7M → $30.9M (-$29.8M)

Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
9
Reduced
10
Closed
7
Calls
$411K
Puts
$160K
Net Calls
+$251K
Net Calls Change
-$60K

Top Buyers

1
LPC
Lion Point Capital
New York
+$3.26M
2
Morgan Stanley
Morgan Stanley
New York
+$1.84M
3
AFA
Alta Fundamental Advisers
New York
+$1.34M
4
BlackRock
BlackRock
New York
+$1.33M
5
BCM
BML Capital Management
Indiana
+$461K

Top Sellers

1
VA
VR Adviser
New York
-$3.48M
2
Goldman Sachs
Goldman Sachs
New York
-$3.27M
3
Barclays
Barclays
United Kingdom
-$1.06M
4
AAA
Affinity Asset Advisors
New York
-$1.04M
5
JP Morgan Chase
JP Morgan Chase
New York
-$634K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$29.4K – – –
BWG
27
Beta Wealth Group
California
$23.6K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$23.5K -$8.79K -3,239 -19%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$22.2K +$36.1K +13,299 New
EGM
30
Engineers Gate Manager
New York
$21.9K +$35.7K +13,135 New
Creative Planning
31
Creative Planning
Kansas
$21.8K – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$17.8K -$634K -233,694 -96%
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$17.5K – – –
VFA
34
Valeo Financial Advisors
Indiana
$16.7K -$300K -110,699 -92%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$10.2K +$10.9K +4,000 +190%
National Bank of Canada
36
National Bank of Canada
Quebec, Canada
$6.85K – – –
Simplex Trading
37
Simplex Trading
Illinois
$1K +$2.95K +1,086 New
IGWM
38
ICA Group Wealth Management
Colorado
$334 +$543 +200 New
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$324 – – –
OLVIG
40
Oliver Lagore Vanvalin Investment Group
Michigan
$167 – – –
AAA
41
Affinity Asset Advisors
New York
– -$1.04M -335,068 Closed
Marshall Wace
42
Marshall Wace
United Kingdom
– -$351K -113,187 Closed
GCP
43
GSA Capital Partners
United Kingdom
– -$151K -48,796 Closed
Squarepoint
44
Squarepoint
New York
– -$127K -41,109 Closed
LP
45
LMR Partners
United Kingdom
– -$119K -38,495 Closed
Bank of America
46
Bank of America
North Carolina
– -$6.06K -1,955 Closed
UBS Group
47
UBS Group
Switzerland
– -$5.25K -1,693 Closed
1
2

MIST Hedge Fund Activity: Q4 2023 in Review

40 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q4 2023, worth a combined $30.9M — down 49% from $60.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MIST positions and 7 closed out — a net gain of 1 holder — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Lion Point Capital, adding an estimated $3.26M. The largest seller was VR Adviser, cutting an estimated $3.48M.

  • 40 institutional investors held Milestone Pharmaceuticals (MIST) as of Q4 2023, up from 39 in Q3 2023.
  • Funds reported $30.9M of Milestone Pharmaceuticals stock for Q4 2023, down 49% quarter-over-quarter.
  • 8 funds opened new Milestone Pharmaceuticals positions in Q4 2023 and 7 closed out, a net change of +1 holder.
  • The largest Milestone Pharmaceuticals buyer in Q4 2023 was Lion Point Capital, an estimated $3.26M added.
  • The largest Milestone Pharmaceuticals seller in Q4 2023 was VR Adviser, an estimated $3.48M sold.

Based on aggregated 13F filings for Q4 2023.